We observed the expected reduction in the trabecular bone volume in Col1a1-Krm2-transgenic NSG mice compared to NSG controls, but there was no further impact caused by the injection of tumor cells (Figure 1B). This evidence concerns the gene COL1A1 and neoplasm.